Search
for

    Sort by

    Research 30 of 41

    1. NEW FORMULATIONS: Glatiramer acetate Australian Prescriber · 2004
    2. Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management The Neurologist · 2002 · 45 citations
    3. BH25 Alopecia in a patient undergoing multiple treatments for multiple sclerosis: a rare presentation and case review British Journal of Dermatology · 2025
    4. Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management Expert Review of Neurotherapeutics · 2006 · 18 citations
    5. Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis Neurodegenerative disease management · 2013
    6. Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management Multiple Sclerosis Journal · 2004 · 37 citations
    7. Teriflunomide: a novel oral treatment for relapsing multiple sclerosis Expert Opinion on Pharmacotherapy · 2014 · 16 citations
    8. NEW PROPRIETARY BRANDS: Gabapentin Australian Prescriber · 2004
    9. NEW PROPRIETARY BRANDS: Cephalexin Australian Prescriber · 2004
    10. New drugs: Agalsidase beta Australian Prescriber · 2004
    11. NEW FORMULATIONS: Sodium cromoglycate Australian Prescriber · 2004
    12. NEW PROPRIETARY BRANDS: Cefaclor monohydrate Australian Prescriber · 2004
    13. Teriflunomide and Its Mechanism of Action in Multiple Sclerosis Drugs · 2014 · 253 citations
    14. The PDGF/PDGFR pathway as a drug target Molecular Aspects of Medicine · 2017 · 182 citations
    15. Drug Reactions Affecting Hair: Diagnosis Dermatologic Clinics · 2007 · 85 citations
    16. Drug-Induced Hair Disorders Current Drug Safety · 2006 · 40 citations
    17. Drug Repurposing - Hypothesis, Molecular Aspects and Therapeutic Applications IntechOpen eBooks · 2020 · 39 citations
    18. Therapeutic Applications of Nanoemulsion Based Drug Delivery Systems: A Review of Patents in Last Two Decades Recent Patents on Drug Delivery & Formulation · 2011 · 39 citations
    19. Teriflunomide (Aubagio®) for the treatment of multiple sclerosis Experimental Neurology · 2014 · 36 citations
    20. Teriflunomide in multiple sclerosis: an update Neurodegenerative disease management · 2016 · 20 citations
    21. Real-World Observational Evaluation of Hair Thinning in Patients with Multiple Sclerosis Receiving Teriflunomide: Is It an Issue in Clinical Practice? Neurology and Therapy · 2018 · 5 citations
    22. ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT The Journal of Rheumatology · 2025 · 1 citations
    23. ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES The Journal of Rheumatology · 2025
    24. THERAPEUTIC CHALLENGES IN POLYAUTOIMMUNITY: ANIFROLUMAB FOR LUPUS ERYTHEMATODES IN OVERLAPPING AUTOIMMUNE SYNDROMES The Journal of Rheumatology · 2025
    25. MIXED CONNECTIVE TISSUE DISEASE EVOLVING FROM THE SEQUENTIAL OVERLAP OF SYSTEMIC LUPUS ERYTHEMATOSUS, SJÖGREN’S SYNDROME, RHEUMATOID ARTHRITIS AND DERMATOMYOSITIS: A FOLLOW-UP The Journal of Rheumatology · 2025
    26. Hair Changes due to Drugs Elsevier eBooks · 2018
    27. Subject Index Journal of The American Academy of Dermatology · 2014
    28. Australasian Society for Dermatology Research Meeting, May 2007 Journal of Investigative Dermatology · 2007
    29. Hair loss due to treatment of multiple sclerosis Neurologie pro praxi · 2017
    30. Teriflunomide: A Once-daily Oral Medication for the Treatment of Relapsing Forms of Multiple Sclerosis Clinical Therapeutics · 2015 · 39 citations